InspireMD Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.62
- 52-Week Range
- $0.60 – $2.57
- Market Cap
- $28.94M
- P/E (TTM)
- —
- EPS (TTM)
- -0.62
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 0.93
- PEG Ratio
- —
- Return on Equity
- -202.81%
- Return on Assets
- -85.85%
- Gross Margin
- 18.05%
- Operating Margin
- -815.64%
- Profit Margin
- 0.00%
- Current Ratio
- 3.80
- Debt/Equity
- 0.10
- Total Debt
- $3.02M
- Free Cash Flow
- $-23.11M
- Revenue Growth
- -0.40%
- Earnings Growth
- —
- Enterprise Value
- $1.54M
Market Snapshot
About
InspireMD Inc. develops and manufactures stent systems with MicroNet mesh technology for treating vascular disease. The company focuses on carotid artery stenting and peripheral vascular interventions where embolic protection is critical. InspireMD markets its CGuard stent system designed to reduce stroke risk during carotid procedures by preventing plaque debris from dislodging.